Cognitive function and breast cancer: Promise and potential insights from functional brain imaging

Breast Cancer Research and Treatment

Volumn 137, Issue 1, 2013, Pages 33-43

  Reuter Lorenz, Patricia A ^a   Cimprich, Bernadine ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adjuvant treatment; Chemotherapy; Cognition; Functional magnetic resonance imaging; Neuropsychology

Indexed keywords

ADJUVANT CHEMOTHERAPY; ATTENTION; BREAST CANCER; COGNITION; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAM; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; IMAGE PROCESSING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION; TRACTOGRAPHY; WORKING MEMORY;

BRAIN; BREAST NEOPLASMS; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84871793917     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2266-3     Document Type: Review

References (70)

1. American Cancer Society (2012) Breast cancer facts and figures 2011-2012. American Cancer Society Inc., Atlanta
2. Trudeau M, Charbonneau F, Gelmon K, Laing K, Latreille J, Mackey J, McLeod D, Pritchard K, Provencher L, Verma S (2005) Selection of adjuvant chemotherapy for treatment of node-positive breast cancer. Lancet Oncol 6(11):886-898
3. Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv 3(4):223-232
4. Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12(3):267-275
5. Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12(7):703-708
6. Ahles TA, Saykin A (2001) Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 19(8):812-820
7. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9(7):967-982
8. Castellon SA, Silverman DH, Ganz PA (2005) Breast cancer treatment and cognitive functioning: current status and future challenges in assessment. Breast Cancer Res Treat 92(3):199-206
9. Tannock IF, Ahles TA, Ganz PA, Van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22(11):2233-2239
10. Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2008) Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110(1):143-152
11. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Munzel K (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109(9):1905-1913
12. Hedayati E, Schedin A, Nyman H, Alinaghizadeh H, Albertsson M (2011) The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncol 50(7):1027-1036
13. Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Holland J (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54(6):925-931
14. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study. Breast 14(2):142-150
15. Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123(1):25-34
16. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292-2299
17. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116(14):3348-3356
18. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28(29):4434-4440
19. Stern Y (2009) Cognitive reserve. Neuropsychologia 47(10):2015-2028
20. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19(10):1647-1656
21. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G, Shah E, Stein R, Whitehead S, Winstanley J (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94(6):828-834
22. Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30(10):1080-1086
23. Huettel SA, Song AW, McCarthy G (2009) Functional magnetic resonance imaging, 2nd edn. Sinauer Associates, Sunderland, MA
24. Poldrack RA, Mumford JA, Nichols TE (2011) Handbook of functional MRI data analysis. Cambridge University Press, New York, NY
25. Poldrack RA (2007) Region of interest analysis for fMRI. Soc Cogn Affect Neurosci 2(1):67-70
26. Reuter-Lorenz PA, Lustig C (2005) Brain aging: reorganizing discoveries about the aging mind. Curr Opin Neurobiol 15(2):245-251
27. Yarkoni T, Poldrack RA, Van Essen DC, Wager TD (2010) Cognitive neuroscience 2.0: building a cumulative science of human brain function. Trends Cogn Sci 14(11):489-496
28. Logothetis NK (2008) What we can do and what we cannot do with fMRI. Nature 453(7197):869-878
29. Schleim S, Roiser JP (2009) FMRI in translation: the challenges facing real-world applications. Frontiers Hum Neurosci 3:63
30. D' Esposito M (2006) Functional MRI: applications in clinical neurology and psychiatry. Taylor and Francis, New York
31. Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Frontiers Syst Neurosci 4:19
32. Jonides J, Lewis RL, Nee DE, Lustig CA, Berman MG, Moore KS (2008) The mind and brain of short-term memory. Annu Rev Psychol 59:193-224
33. de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, Boven E, Schagen SB (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 32(8):1206-1219
34. Kesler SR, Kent JS, O'Hara R (2011) Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68(11):1447-1453
35. Kesler SR, Bennett FC, Mahaffey ML, Spiegel D (2009) Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin Cancer Res 15(21):6665-6673
36. Mattay VS, Goldberg TE (2004) Imaging genetic influences in human brain function. Curr Opin Neurobiol 14(2):239-247
37. Raemaekers M, Ramsey NF, Vink M, van den Heuvel MP, Kahn RS (2006) Brain activation during antisaccades in unaffected relatives of schizophrenic patients. Biol Psychiatry 59(6):530-535
38. Dumontheil I, Klingberg T (2011) Brain activity during a visuospatial working memory task predicts arithmetical performance 2 years later. Cereb Cortex 22(5):1078-1085
39. Yang Z, Yeo RA, Pena A, Ling JM, Klimaj S, Campbell R, Doezema D, Mayer AR (2012) An fMRI study of auditory orienting and inhibition of return in pediatric mild traumatic brain injury. J Neurotrauma. doi: 10.1089/neu.2012.2395
40. Reuter-Lorenz PA, Cappell KA (2008) Neurocognitive aging and the compensation hypothesis. Curr Dir Psychol Sci 17(3):177-182
41. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25(25):3866-3870
42. Schneider-Garces NJ, Gordon BA, Brumback-Peltz CR, Shin E, Lee Y, Sutton BP, Maclin EL, Gratton G, Fabiani M (2010) Span, CRUNCH, and beyond: working memory capacity and the aging brain. J Cogn Neurosci 22(4):655-669
43. Cappell KA, Gmeindl L, Reuter-Lorenz PA (2010) Age differences in prefrontal recruitment during verbal working memory maintenance depend on memory load. Cortex 46(4):462-473
44. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30(20):2500-2508
45. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123(3):819-828
46. Biswal BB (2012) Resting state fMRI: a personal history. Neuroimage 62(2):938-944
47. Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, Wu T, Jiang T, Li K (2006) Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 31(2):496-504
48. Tian L, Jiang T, Wang Y, Zang Y, He Y, Liang M, Sui M, Cao Q, Hu S, Peng M, Zhuo Y (2006) Altered resting-state functional connectivity patterns of anterior cingulate cortex in adolescents with attention deficit hyperactivity disorder. Neurosci Lett 400(1-2):39-43
49. Monk CS, Peltier SJ, Wiggins JL, Weng SJ, Carrasco M, Risi S, Lord C (2009) Abnormalities of intrinsic functional connectivity in autism spectrum disorders. Neuroimage 47(2):764-772
50. Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124:1-38
51. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci USA 98(2):676-682
52. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME (2005) The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA 102(27):9673-9678
53. Weissman DH, Roberts KC, Visscher KM, Woldorff MG (2006) The neural bases of momentary lapses in attention. Nat Neurosci 9(7):971-978
54. Berman MG, Peltier S, Nee DE, Kross E, Deldin PJ, Jonides J (2011) Depression, rumination and the default network. Soc Cogn Affect Neurosci 6(5):548-555
55. Smallwood J, Beach E, Schooler JW, Handy TC (2008) Going AWOL in the brain: mind wandering reduces cortical analysis of external events. J Cogn Neurosci 20(3):458-469
56. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 29(6):1860-1873
57. Cook DB, O'Connor PJ, Lange G, Steffener J (2007) Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage 36(1):108-122
58. Lim J, Wu WC, Wang J, Detre JA, Dinges DF, Rao H (2010) Imaging brain fatigue from sustained mental workload: an ASL perfusion study of the time-on-task effect. Neuroimage 49(4):3426-3435
59. Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue: implications for breast cancer survivors. Cancer 118(8 Suppl):2261-2269
60. Bruno J, Hosseini SM, Kesler S (2012) Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis. doi: 10.1016/j.nbd.2012.07.009
61. Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, Berman MG, Hayes DF, Noll DC, Peltier S, Welsh RC (2010) Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32(3):324-331
62. Hedayati E, Alinaghizadeh H, Schedin A, Nyman H, Albertsson M (2012) Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur J Oncol Nurs 16(3):315-322
63. Reid-Arndt SA, Hsieh C, Perry MC (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology 19(5):535-544
64. Vearncombe KJ, Rolfe M, Andrew B, Pachana NA, Wright M, Beadle G (2011) Cognitive effects of chemotherapy-induced menopause in breast cancer. Clin Neuropsychol 25(8):1295-1313
65. Scherling C, Collins B, Mackenzie J, Bielajew C, Smith A (2011) Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Frontiers Hum Neurosci 5:122
66. Scherling C, Collins B, Mackenzie J, Bielajew C, Smith A (2012) Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. J Clin Exp Neuropsychol 34(5):543-560
67. Bennett CM, Miller MB (2010) How reliable are the results from functional magnetic resonance imaging? Ann N Y Acad Sci 1191:133-155
68. Nagel IE, Preuschhof C, Li SC, Nyberg L, Backman L, Lindenberger U, Heekeren HR (2009) Performance level modulates adult age differences in brain activation during spatial working memory. Proc Natl Acad Sci USA 106(52):22552-22557
69. Lane RD, Wager TD (2009) Introduction to a special issue of neuroimage on brain-body medicine. Neuroimage 47(3):781-784
70. de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB (2011) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp. doi: 10.1002/hbm.21422